Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- sustained-release gemcitabine-docetaxelNDV-01Phase 31 trial
Relmada Therapeutics, Inc. · Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Urothelial Carcinoma Bladder
- SuvemcitugPhase 31 trial
Jiangsu Simcere Pharmaceutical Co., Ltd. · Refractory Metastatic Colorectal Cancer
- TBI-1301Phase 31 trial
Takara Bio Inc. · Synovial Sarcomas
- TilesizumabBGB-108Phase 31 trial
Qilu Pharmaceutical Co., Ltd. · Lung Cancer
- UtomilumabPhase 31 trial
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- varegacestatAL102Phase 31 trial
Immunome, Inc. · Desmoid, Desmoid Tumor
- VC004Phase 31 trial
Jiangsu vcare pharmaceutical technology co., LTD · Locally Advanced Solid Tumor
- YK-209APhase 31 trial
Suzhou Puhe Pharmaceutical Technology Co., LTD · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- ZovegalisibPhase 31 trial
Relay Therapeutics, Inc. · PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor
- MK-4830Phase 210 trials
Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma
- SI-B003Phase 210 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck
- SHR-9839Phase 28 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors, Advanced Esophageal Squamous Cell Carcinoma, Non-small Cell Lung Cancer (NSCLC)
- BL-M08D1Phase 26 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Solid Tumors, Gastrointestinal Tumors, Diffuse Large B-Cell Lymphoma
- RO7247669Tobemstomig, RG6139Phase 26 trials
Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer
- SKB571Phase 26 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Lung Cancer (Non-Small Cell), Non-Small Cell Lung Cancer, Gastrointestinal Tumors
- VibostolimabMK-7684Phase 26 trials
Merck & Co. · Melanoma, Carcinoma, Non-Small-Cell Lung, Metastatic Urothelial Carcinoma
- Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials
Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)
- EvorpaceptALX148Phase 25 trials
ALX Oncology Inc. · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer, Metastatic
- GFH276Phase 25 trials
Genfleet Therapeutics (Shanghai) Inc. · RAS Mutation, Pancreatic Cancer, Non-small Cell Lung Cancer (NSCLC)
- PalacaparibAZD9574Phase 25 trials
AstraZeneca · Metastatic Prostate Cancer, Ovarian Cancer, Endometrial Cancer
- SHR-1826Phase 25 trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Resectable Non-small Cell Lung Cancer
- zamtocabtagene autoleucelMB-CART2019.1Phase 25 trials
Miltenyi Biomedicine GmbH · CAR T Cell Therapy, Mantle Cell Lymphoma (MCL), Multiple Sclerosis
- Zelenectide pevedotinBT8009Phase 25 trials
BicycleTx Limited · Breast Cancer, Non-Small Cell Lung Cancer, Advanced Solid Tumors
- AB928Etrumadenant, ETRUMAPhase 24 trials
Arcus Biosciences, Inc. · Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer
- ABSK043Phase 24 trials
Abbisko Therapeutics Co, Ltd · Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive, HER2-Gastric/Gastroesophageal Junction Cancer
- APG-115Phase 24 trials
Ascentage Pharma Group Inc. · T-Prolymphocytic Leukemia, Non-Hodgkins Lymphoma, Liposarcoma
- BenmelstobartPhase 24 trials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Alveolar Soft Part Sarcoma, Non-Small Cell Lung Cancer, Gastroesophageal Adenocarcinoma
- BotensilimabAGEN1181, 8541APhase 24 trials
Agenus Inc. · Metastatic Colorectal Cancer, Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC), Untreated
- DabogratinibTYRA-300Phase 24 trials
Tyra Biosciences, Inc · FGFR3 Gene Mutation, FGFR3 Gene Alteration, Achondroplasia
- EnvafolimabPhase 24 trials
3D Medicines (Sichuan) Co., Ltd. · Biliary Tract Neoplasms, Solid Tumor, Solid Tumors
- FPI-2265AZD2265, 225Ac-PSMA-I&TPhase 24 trials
Fusion Pharmaceuticals Inc. · Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Metastatic Castration Resistant Prostate Cancer
- GecacitinibPhase 24 trials
Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Lymphoma, Non-small Cell Lung Cancer, Advanced Solid Tumor
- IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials
Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma
- INO-9012Phase 24 trials
Geneos Therapeutics · HCC, Glioblastoma, Urothelial Carcinoma
- luxdegalutamideJSB462, ARV-766Phase 24 trials
Novartis · Prostatic Cancer, Castration-Resistant, Progressive Metastatic Castrate Resistant Prostate Cancer, Prostate Cancer Metastatic
- MHB039APhase 24 trials
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor, Advanced Breast Cancer, Advanced Lung Cancer
- MK-2010LM-299Phase 24 trials
Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm, Malignant Tumors
- MK-3120SKB410Phase 24 trials
Merck & Co. · Bladder Cancer, Advanced Solid Tumors, Malignant Neoplasm
- RO7198457Autogene CevumeranPhase 24 trials
Roche (Genentech) · Colorectal Cancer Stage II, Colorectal Cancer Stage III, Adenocarcinoma, Pancreatic Ductal
- T3011Phase 24 trials
Shanghai Pharmaceuticals Holding Co., Ltd · Advanced Solid Tumors, Nonmuscle-invasive Bladder Cancer, Solid Tumor
- TUB-040Phase 24 trials
Gilead Sciences · Ovarian Cancer, Non-small Cell Lung Cancer, Uterine Endometrial Cancer
- UbamatamabREGN4018Phase 24 trials
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- VS-7375Phase 24 trials
Verastem, Inc. · G12D Mutated KRAS, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)
- ADCAntibody-drug conjugate, ADCE-D01Phase 23 trials
MBrace Therapeutics · Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer, Colo-rectal Cancer
- ADG126Phase 23 trials
Adagene Inc · Advanced/Metastatic Solid Tumors, Solid Tumor, Advanced Liver Cancers
- AK130Phase 23 trials
Akeso · Biliary Tract Cancer, Hepatocellular Carcinoma, Pancreatic Cancer
- AK146D1Phase 23 trials
Akeso · Advanced Non Small Cell Lung Cancer (NSCLC), Advanced Breast Cancer, Urothelial Carcinoma (UC)
- AlisertibPB-8237, MLN8237Phase 23 trials
Puma Biotechnology, Inc. · Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer
- AnvumetostatAMG 193Phase 23 trials
Amgen · Advanced MTAP-null Solid Tumors, MTAP-deleted NSCLC, MTAP-null Non-Small-Cell Lung Cancer
- AZD4205Phase 23 trials
Dizal Pharmaceuticals · Non-small Cell Lung Cancer, Peripheral T-cell Lymphoma, Peripheral T Cell Lymphoma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.